SILC (Nasdaq: SILC) insider plans Rule 144 sale of 2,500 ordinary shares

Rhea-AI Filing Summary

Yuval Karp filed to sell up to 2,500 ordinary shares under Rule 144 through Oppenheimer & Co. Inc. The shares are listed with an aggregate market value of $114,775.00. The issuer reports 5,706,142 ordinary shares outstanding and plans the sale on or about 08/12/2026 on Nasdaq. The shares to be sold were acquired upon exercise of employee stock options with a cash payment upon exercise. In the preceding three months, Karp sold 2,000 ordinary shares on 05/18/2026 for $100,000.00.

Key Figures

Shares to be sold: 2,500 ordinary shares Aggregate market value of planned sale: $114,775.00 Shares outstanding: 5,706,142 ordinary shares +3 more

6 metrics

Shares to be sold 2,500 ordinary shares Planned Rule 144 sale through Oppenheimer & Co. Inc.

Aggregate market value of planned sale $114,775.00 Value associated with 2,500 ordinary shares to be sold

Shares outstanding 5,706,142 ordinary shares Issuer’s ordinary shares outstanding in connection with the Rule 144 notice

Recent shares sold 2,000 ordinary shares Shares sold on 05/18/2026 during the past 3 months

Value of recent sale $100,000.00 Aggregate value of 2,000 shares sold on 05/18/2026

Planned sale date 08/12/2026 Approximate date of proposed Rule 144 sale on Nasdaq

Key Terms

Rule 144, aggregate market value, employee stock options, cash payment upon exercise of stock options

4 terms

Rule 144 regulatory

"filed to sell up to 2,500 ordinary shares under Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

aggregate market value financial

"listed with an aggregate market value of $114,775.00"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

employee stock options financial

"Shares acquired upon exercise of employee stock options"

Employee stock options are contracts that give workers the right to buy a company's shares at a set price sometime in the future, like a coupon that lets you purchase stock at today’s price later on. Investors care because they align employees’ incentives with company performance and create a potential future claim on shares that can reduce existing owners’ percentage and add to a company’s reported compensation costs.

cash payment upon exercise of stock options financial

"Cash payment upon exercise of stock options"

FAQ

What does the SILC Rule 144 filing disclose about planned share sales?

The filing discloses that Yuval Karp intends to sell up to 2,500 ordinary shares under Rule 144 through Oppenheimer & Co. Inc., with an aggregate market value of $114,775.00, targeting a sale date around 08/12/2026 on Nasdaq.

How many SILC shares has Yuval Karp sold recently?

In the past three months, Yuval Karp sold 2,000 ordinary shares on 05/18/2026 for $100,000.00. These sales are reported alongside the planned additional sale of 2,500 shares under the current Rule 144 notice.

What is the market value of the SILC shares Karp plans to sell?

The planned sale covers 2,500 ordinary shares with an aggregate market value of $114,775.00. This value is reported in connection with the proposed Rule 144 transaction to be executed on or about 08/12/2026 through Oppenheimer & Co. Inc.

How does Karp’s planned SILC share sale compare to shares outstanding?

The issuer reports 5,706,142 ordinary shares outstanding. Karp’s planned Rule 144 sale involves 2,500 shares, providing context for the scale of the proposed transaction relative to the issuer’s total ordinary shares.

How were the SILC shares in the Rule 144 filing acquired?

The 2,500 ordinary shares covered by the Rule 144 notice were acquired upon exercise of employee stock options, with a cash payment upon exercise of stock options as described in the securities information section.

Which broker and market are involved in the planned SILC share sale?

The planned Rule 144 sale of 2,500 ordinary shares will be handled by Oppenheimer & Co. Inc. and is listed for execution on Nasdaq around 08/12/2026, according to the securities information provided.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 09:10 AM Accepted by SEC EDGAR 08/13/2026 - 09:09 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	2500	114775.00	5706142	08/12/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	08/12/2026	Shares acquired upon exercise of employee stock options	SILICOM LTD.			2500	08/12/2026	Cash payment upon exercise of stock options

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Yuval Karp 14 ATIR YEDA ST. KFAR-SAVA L3 4464323	Ordinary Shares	05/18/2026	2000	100000.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)